GEODE CAPITAL MANAGEMENT, LLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$55,812,538
+44.9%
1,103,306
+33.8%
0.01%
+40.0%
Q2 2023$38,505,584
+51.1%
824,707
+23.8%
0.01%
+66.7%
Q1 2023$25,478,380
+73305.7%
665,927
+5.1%
0.00%
-40.0%
Q4 2022$34,709
-99.8%
633,380
+21.0%
0.01%
+66.7%
Q3 2022$17,817,000
+302.9%
523,289
+11.8%
0.00%
+200.0%
Q2 2022$4,422,000
-29.7%
467,985
+5.5%
0.00%0.0%
Q1 2022$6,292,000
-28.6%
443,473
+6.4%
0.00%0.0%
Q4 2021$8,812,000
+4.4%
416,681
+10.3%
0.00%0.0%
Q3 2021$8,441,000
-6.2%
377,693
+4.2%
0.00%0.0%
Q2 2021$8,995,000
+17.2%
362,578
+37.1%
0.00%0.0%
Q1 2021$7,672,000
+23.1%
264,483
+9.4%
0.00%0.0%
Q4 2020$6,234,000
-13.4%
241,662
+3.3%
0.00%0.0%
Q3 2020$7,200,000
+106.5%
233,870
+67.1%
0.00%0.0%
Q2 2020$3,487,000
+44.4%
139,967
+22.9%
0.00%0.0%
Q1 2020$2,414,000
-31.3%
113,907
-28.1%
0.00%
Q4 2019$3,516,000
+107.4%
158,488
+112.6%
0.00%
Q3 2019$1,695,00074,5310.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders